Labeling Error Prompts 28,000-Bottle Recall of Abbvie’s Thyroid Drug

Drug Industry Daily
A A
Abbvie, the new biopharma spinoff from Abbott Laboratories, is recalling more than 28,000 bottles of its thyroid drug Synthroid due to a labeling error that could result in patients taking the wrong dose.

To View This Article:

Login

Subscribe To Drug Industry Daily